1. 312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition. (9th November 2020) Authors: Tarhini, Ahmad; Kang, Ni; Lee, Sandra; Stephen Hodi, F; Cohen, Gary; Hamid, Omid; Hutchins, Laura; Sosman, Jeffrey; Kluger, Harriett; Eroglu, Zeynep; Koon, Henry; Lawrence, Donald; Kendra, Kari; Minor, David; Lee, Carrie; Albertini, Mark; Flaherty, Lawrence; Petrella, Teresa; Striecher, Howard; S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗